MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
National Defense
July 2007
Manik K. Rath
Mergers, Acquisitions Call for Added Scrutiny When acquiring or merging with any government contractor, reviewing ethics policies, compliance programs, and all recent voluntary disclosures will provide a wealth of invaluable information. mark for My Articles similar articles
Job Journal
July 3, 2005
Michael Kinsman
Career Pros: Leading by Example Executives help establish the standards that drive the behavior of other workers. When executives embrace corporate values and live up to them, they provide standards for everyone to follow. mark for My Articles similar articles
IndustryWeek
January 1, 2008
David Blanchard
How Ethical is Your Supply Chain? Supplier ethics management offers a way to plug global ethic gaps. mark for My Articles similar articles
Chemistry World
March 13, 2007
Vioxx Trial Blow for Merck A jury has awarded $47.5 million to an Idaho man after finding that the anti-inflammatory drug Vioxx, made by Merck and Co., Inc., contributed to his heart attack. mark for My Articles similar articles
BusinessWeek
April 21, 2011
Tom Randall
Merck's Risky Bet on Research CEO Frazier, who made his name fighting drug lawsuits, is investing billions to churn out new medicines. mark for My Articles similar articles
National Defense
June 2015
Sandra Evers-Manly
An Ethical Culture: Own it, Live it, Lead it Anyone involved in ethics and compliance within the defense industry should know that to be truly effective, a corporate ethics program requires more than a "check the box" approach mark for My Articles similar articles
CRM
March 2005
Barton Goldenberg
Let's Keep to the High Road To move the CRM industry forward, leaders must learn from others' mistakes and stay focused on what's important. mark for My Articles similar articles
Entrepreneur
May 2003
Kimberly L. McCall
Devil's Advocate Do your sales reps know how far is too far when it comes to landing that sale? mark for My Articles similar articles
The Motley Fool
November 29, 2010
Brian Orelli
There's Still Only One Merck KGaA's oral MS drug delay is Novartis' gain. mark for My Articles similar articles
National Defense
October 2015
Berry & Hutchens
Creating an Ethics Compliance Program Government agencies and mature prime contractors expect emerging contractors to reflect the same "culture of ethics and compliance" that large companies commit substantial resources to implementing. mark for My Articles similar articles
The Motley Fool
January 21, 2011
Brian Orelli
Mark Your Calendar, Drug Investors Vertex announces that the Food and Drug Administration has accepted its New Drug Application to market telaprevir. mark for My Articles similar articles
CRM
January 2014
Barton Goldenberg
Integrating Social Media Is a Strategy for Success Expand your insights with a hub and spoke model. mark for My Articles similar articles
National Defense
January 2006
Reeder & Hickey
Make Commitment To Corporate Ethics The National Defense Industrial Association puts ethical conduct on par with shareholder profits and believes maintaining the highest ethical standards throughout the defense industry has never been more important to the country. mark for My Articles similar articles
The Motley Fool
April 6, 2011
Brian Orelli
Merck Inspired to Eye Growth A bolt-on acquisition of eye-care specialist Inspire. mark for My Articles similar articles
Bio-IT World
December 15, 2004
Kevin Davies
Patients Before Profits? After the Vioxx disaster, Pharma needs to reassure patients that they come first. mark for My Articles similar articles
The Motley Fool
February 3, 2011
Brian Orelli
Get Ready for Merck's Bumpy Ride Long-term earnings guidance gets thrown out the window. mark for My Articles similar articles
The Motley Fool
December 3, 2010
Brian Orelli
Merck Smartens Up The acquisition of SmartCells looks like an intelligent move. mark for My Articles similar articles
BusinessWeek
April 23, 2007
Alex Halperin
Vioxx Casts A Long, Long Shadow More than two years after Merck & Co. pulled its Vioxx painkiller from shelves over heart attack and stroke risks, the Food & Drug Administration is still skittish about the safety of drugs currently on the market and those coming up for review. mark for My Articles similar articles
The Motley Fool
May 5, 2010
Brian Orelli
Doubled Revenue, but Not High Growth An acquisition and some rearrangements make Merck's revenue line sound better than it is. mark for My Articles similar articles
CRM
August 2, 2004
Jerri Ledford
Reducing CRM's Total Cost of Ownership How organizations increase the value of their CRM initiatives while keeping costs low. mark for My Articles similar articles
CRM
October 18, 2004
The Pulse: In 2005 we Plan to... A chart summarizing in what direction companies plan to move regarding CRM spending. mark for My Articles similar articles
CRM
August 2011
Barton Goldenberg
Overcoming Skepticism to Exploit Social CRM Many executives fear a healthy two-way conversation with customers. mark for My Articles similar articles
CRM
June 2005
Jim Dickie
A Little Help From Your Friends A new crop of CRM services firms help solve data-related frustrations. mark for My Articles similar articles
The Motley Fool
June 1, 2005
Chuck Saletta
Where Angels Fear to Tread In the right situation, short-term corporate crises can provide superior long-term possibilities. Of course, investing in companies in crisis comes with risk. mark for My Articles similar articles
CRM
August 4, 2015
David Myron
Social CRM Mistakes and How to Avoid Them Follow these 10 steps to deploy a successful social CRM strategy. mark for My Articles similar articles
CRM
March 1, 2004
Lisa Picarille
CRM Helps Professional Services Firms Obey the Law When professional services firms purchase CRM systems, they want those systems up-to-date in terms of compliance and the flexibility to conform to future laws and regulations. mark for My Articles similar articles
The Motley Fool
January 14, 2011
Brian Orelli
Don't Have a Stroke Over Merck's Heart Drug Welcome to pharma investing. mark for My Articles similar articles
The Motley Fool
January 27, 2004
Jeff Hwang
Merck in the Balance These are troubled times for Merck. Restructuring charges, Zocor sales woes, and a new distribution program hamper earnings. mark for My Articles similar articles
The Motley Fool
June 23, 2005
Rich Smith
Dueling Fools: Merck Bull Rebuttal Priced at a P/E of 13 and paying you a 4.8% dividend, Merck isn't just affordable -- it's a stock you can't afford not to own. mark for My Articles similar articles